Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
about
Total and corrected antioxidant capacity in hemodialyzed patientsModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsPlasma biomarkers of oxidant stress and development of organ failure in severe sepsis.Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise.Glycemic load is associated with oxidative stress among prevalent maintenance hemodialysis patientsClinical factors associated with plasma F2-isoprostane levels in HIV-infected adults.Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study.Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease.A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients.Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patientsComparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stressRelation of blood cadmium, lead, and mercury levels to biomarkers of lipid peroxidation in premenopausal women.Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney diseaseSerum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal AnemiaCystatin C, other markers of kidney disease, and incidence of age-related cataract.Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation.Cardiovascular Complications in CKD Patients: Role of Oxidative Stress.Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies.Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy.The effect of N-acetylcysteine on oxidative serum biomarkers of hemodialysis patients.The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.Effects of Omega-3 Fatty Acids on Markers of Inflammation in Patients With Chronic Kidney Disease: A Controversial Issue.
P2860
Q24791714-6E95D53B-7AF2-4C69-913A-6FEB9669151DQ28074264-D5975273-821A-4E38-BC67-497336C65C68Q33394380-058F03C7-25D2-49DD-BDF0-271C71C182BCQ33630922-754A6BC0-17EB-4B14-8912-AF6C611395A7Q33749291-DB735E34-3CB6-4012-897C-E75C3DAF31F9Q33936089-770F3EEC-A59D-4E5A-B7F3-C2BDD1612350Q34422837-F6490BAB-3D57-41D9-9025-AB70D5720021Q34806160-AA3392C1-C77A-4A6B-9930-D7DC05792453Q34808918-67F3ABC3-3049-49F0-9518-C5E580B2DD00Q35025400-756A3046-EC56-43CA-A483-F94FF2AB65DAQ35524790-A6338139-C5FE-4F42-89DA-66A4C074D1D3Q35653263-199D77BF-FE90-4CD2-A1AC-0E6A222D67E1Q35715691-018F1CC1-CAD7-4C24-A947-05A1E3D835F6Q35818228-B1ED83C9-881D-4DA8-B8D8-B2EC2B1B8DBCQ35831244-92606666-00B7-4DDD-8925-B75CFC29BD06Q35883537-0DBA7F81-FC76-456F-B59E-0D387E83EC1CQ36824691-B4B30444-F786-41C9-847B-560AB1797474Q37207365-DE35C88C-A5B1-44F7-8DC3-9611B80875EDQ37301522-CEF3F958-490B-483A-84D6-7E10C0701AB3Q37604744-6DAC1413-7C8E-4167-9CDD-0AAD2EAB7A4DQ37648699-4D18DC07-576E-44E9-8CC3-03CEDD769C08Q37831154-5C17B7B3-184A-4105-816D-7B86098A2A09Q38165049-8E1665A9-3C2E-42E5-A1D1-159122515629Q38786018-B16282AB-9217-4331-9047-A8EDC3998045Q40193776-C8A8B995-4CE9-446B-AD23-5F1B59084FFCQ42264458-454A4512-1BB9-4D32-A698-598BCCDF91B9Q42427842-33062566-4E3E-465D-B735-1DE21ED6F329Q45904642-A8A991DC-30FA-4757-B183-58C6F327BDF0Q47260247-1EDE86C8-EE6E-4E98-84BD-5347C0A727C2
P2860
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
@en
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
@nl
type
label
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
@en
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
@nl
prefLabel
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
@en
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
@nl
P2093
P356
P1433
P1476
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients
@en
P2093
J A Evanson
J D Morrow
J Himmelfarb
L J Roberts
T A Ikizler
P304
P356
10.5414/CNP58190
P577
2002-09-01T00:00:00Z